Eugena Stamuli

799 total citations
23 papers, 323 citations indexed

About

Eugena Stamuli is a scholar working on Economics and Econometrics, General Health Professions and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eugena Stamuli has authored 23 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 4 papers in General Health Professions and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eugena Stamuli's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Nail Diseases and Treatments (3 papers) and Economic and Financial Impacts of Cancer (3 papers). Eugena Stamuli is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Nail Diseases and Treatments (3 papers) and Economic and Financial Impacts of Cancer (3 papers). Eugena Stamuli collaborates with scholars based in United Kingdom, Ireland and Greece. Eugena Stamuli's co-authors include David Torgerson, Sarah Ronaldson, Catherine Hewitt, Farina Hashmi, Kim S Thomas, Sarah Cockayne, Shalmini Jayakody, Caroline McIntosh, Arthur R Kang’ombe and Kate Hicks and has published in prestigious journals such as Annals of Oncology, Health Technology Assessment and British Medical Bulletin.

In The Last Decade

Eugena Stamuli

22 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugena Stamuli United Kingdom 12 83 78 62 46 36 23 323
Valeska Andreozzi Portugal 12 36 0.4× 34 0.4× 56 0.9× 76 1.7× 34 0.9× 41 342
Olujide Arije Nigeria 10 38 0.5× 55 0.7× 76 1.2× 82 1.8× 15 0.4× 37 356
Yunxian Zhou China 12 39 0.5× 95 1.2× 89 1.4× 49 1.1× 46 1.3× 42 322
Brendan M. Boyle United States 9 65 0.8× 145 1.9× 73 1.2× 39 0.8× 72 2.0× 18 363
Melissa Yee United States 8 21 0.3× 80 1.0× 128 2.1× 57 1.2× 21 0.6× 11 428
Xinchan Jiang Hong Kong 11 40 0.5× 62 0.8× 100 1.6× 57 1.2× 22 0.6× 16 347
Davoud Adham Iran 10 30 0.4× 36 0.5× 76 1.2× 84 1.8× 21 0.6× 38 341
R. Dobson United Kingdom 7 19 0.2× 113 1.4× 41 0.7× 32 0.7× 74 2.1× 88 290
Malcolm Hogan United States 9 24 0.3× 92 1.2× 74 1.2× 37 0.8× 43 1.2× 19 395
Chung-Yeh Deng Taiwan 13 22 0.3× 154 2.0× 35 0.6× 47 1.0× 115 3.2× 20 468

Countries citing papers authored by Eugena Stamuli

Since Specialization
Citations

This map shows the geographic impact of Eugena Stamuli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugena Stamuli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugena Stamuli more than expected).

Fields of papers citing papers by Eugena Stamuli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugena Stamuli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugena Stamuli. The network helps show where Eugena Stamuli may publish in the future.

Co-authorship network of co-authors of Eugena Stamuli

This figure shows the co-authorship network connecting the top 25 collaborators of Eugena Stamuli. A scholar is included among the top collaborators of Eugena Stamuli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugena Stamuli. Eugena Stamuli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stamuli, Eugena, et al.. (2023). Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis. International Journal of Technology Assessment in Health Care. 39(1). e21–e21. 3 indexed citations
2.
Stamuli, Eugena, et al.. (2022). Patient Preferences for Breast Cancer Treatments: A Discrete Choice Experiment in France, Ireland, Poland and Spain. Future Oncology. 18(9). 1115–1132. 11 indexed citations
3.
Stamuli, Eugena & Demosthenes B. Panagiotakos. (2022). The role of epidemiology research in economic evaluation for Health Technology Assessment. 13(3). 96–102. 2 indexed citations
4.
Boukovinas, Ioannis, et al.. (2022). Treatment pathways and associated costs of metastatic colorectal cancer in Greece. Cost Effectiveness and Resource Allocation. 20(1). 7–7. 5 indexed citations
5.
Stafylas, Panagiotis, et al.. (2019). PCV44 COST ANALYSIS OF THE INTRODUCTION OF A SINGLE-PILL COMBINATION OF ROSUVASTATIN AND EZETIMIBE IN THE GREEK SETTING. Value in Health. 22. S548–S548. 2 indexed citations
6.
Geitona, Mary, et al.. (2019). Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system. Journal of Medical Economics. 22(4). 359–364. 6 indexed citations
7.
Corbacho, Belén, Kerry Bell, Eugena Stamuli, et al.. (2017). Cost‐effectiveness of the Family Nurse Partnership (FNP) programme in England: Evidence from the building blocks trial. Journal of Evaluation in Clinical Practice. 23(6). 1367–1374. 15 indexed citations
8.
Geitona, Mary, et al.. (2017). Lacosamide As First Line Treatment Option In Focal Epilepsy; A Cost-Utility Analysis for The Greek Healthcare System. Value in Health. 20(9). A724–A724. 1 indexed citations
9.
Stamuli, Eugena, et al.. (2017). Identifying the primary outcome for a randomised controlled trial in rheumatoid arthritis: the role of a discrete choice experiment. Journal of Foot and Ankle Research. 10(1). 57–57. 16 indexed citations
10.
Stamuli, Eugena, Gerry Richardson, Steven Duffy, Michael Robling, & Kerenza Hood. (2015). Systematic review of the economic evidence on home visitation programmes for vulnerable pregnant women. British Medical Bulletin. 115(1). 19–44. 7 indexed citations
11.
12.
Stamuli, Eugena, Karen Bloor, Hugh MacPherson, et al.. (2012). Cost-effectiveness of acupuncture for irritable bowel syndrome: findings from an economic evaluation conducted alongside a pragmatic randomised controlled trial in primary care. BMC Gastroenterology. 12(1). 149–149. 21 indexed citations
13.
Stamuli, Eugena, Sarah Cockayne, Catherine Hewitt, et al.. (2012). Cost‐effectiveness of cryotherapy versus salicylic acid for the treatment of plantar warts: economic evaluation alongside a randomised controlled trial (EVerT trial). Journal of Foot and Ankle Research. 5(1). 4–4. 16 indexed citations
14.
Stamuli, Eugena, Sarah Cockayne, Catherine Hewitt, et al.. (2012). Cost-effectiveness of cryotherapy versus salicylic acid for the treatment of plantar warts: economic evaluation alongside a randomised controlled trial (EVerT trial). Journal of Foot and Ankle Research. 5(1). 4–4. 2 indexed citations
15.
Cockayne, Sarah, Michael T. Curran, Farina Hashmi, et al.. (2011). EVerT: cryotherapy versus salicylic acid for the treatment of verrucae – a randomised controlled trial.. Health Technology Assessment. 15(32). 1–170. 32 indexed citations
16.
Cockayne, Sarah, Catherine Hewitt, Kate Hicks, et al.. (2011). Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): a randomised controlled trial. BMJ. 342(jun07 1). d3271–d3271. 48 indexed citations
17.
Stamuli, Eugena. (2011). Health outcomes in economic evaluation: who should value health?. British Medical Bulletin. 97(1). 197–210. 46 indexed citations
18.
MacPherson, Hugh, Martin Bland, Karen Bloor, et al.. (2010). Acupuncture for irritable bowel syndrome: A protocol for a pragmatic randomised controlled trial. BMC Gastroenterology. 10(1). 63–63. 19 indexed citations
19.
Doull, Iolo, David Price, Mike Thomas, et al.. (2007). Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma. Current Medical Research and Opinion.
20.
Tabberer, Maggie, et al.. (2006). PCN74 UTILITIES ASSOCIATED WITH NON-SMALL CELL LUNG CANCER (NSCLC): A COMMUNITY STUDY. Value in Health. 9(6). A298–A298. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeska Andreozzi Breakdown of academic impact, for papers by Olujide Arije Breakdown of academic impact, for papers by Yunxian Zhou Breakdown of academic impact, for papers by Brendan M. Boyle Breakdown of academic impact, for papers by Melissa Yee Breakdown of academic impact, for papers by Xinchan Jiang Breakdown of academic impact, for papers by Davoud Adham Breakdown of academic impact, for papers by R. Dobson Breakdown of academic impact, for papers by Malcolm Hogan Breakdown of academic impact, for papers by Chung-Yeh Deng
Rankless by CCL
2026